All Updates

All Updates

icon
Filter
Funding
Sidekick raises USD 55 million in Series B funding
Preventive Healthcare
May 5, 2022
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
Preventive Healthcare

Preventive Healthcare

May 5, 2022

Sidekick raises USD 55 million in Series B funding

Funding

  • Digital therapeutics (DTx) startup Sidekicks has raised USD 55 million (EUR 52 million)  in a Series B funding round led by London-based Novator Ventures, with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor. 

  • The funds will be used to expand its chronic disease treatment programs into new therapeutic areas, as well as to form new partnerships and enhance existing ones with players in the healthcare and pharmaceutical industry. Additionally, the company plans to double its headcount to 240 team members. 

  • The B2B2C DTx company is focused on developing personalized programs for patients with chronic conditions - from cancer to heart health -  and other behavioral conditions such as smoking addiction. Its platform offers gamified content that incorporates lifestyle changes and clinical treatments to improve healthcare outcomes. The firm partners with health plans such as Anthem to reach patients and develops DTx solutions with pharma giants including Pfizer and Bayer. It has served over 40,000 patients globally across the US, Germany, Sweden, and Iceland.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.